Immunohistochemical study: antibodies and conditions of use
| Antibody . | Clone . | Dilution . | Source . |
|---|---|---|---|
| CD20 | L26 | 1:80 | Dako, Carpinteria, CA |
| CD79a | JCB117 | 1:80 | Dako |
| CD3 | PS1 | 1:30 | Novocastra, Newcastle upon Tyne, England |
| CD5 | 4C7 | 1:25 | Novocastra |
| CD10 | 56C6 | 1:25 | Novocastra |
| bcl-2 | 124 | 1:50 | Dako |
| bcl-6 | PG-B6p (52) | 1:5 | Dr B. Falini, Perugia, Italy |
| CD138 | B-B4 | 1:10 | Serotec, Oxford, England |
| p53 | BP53-12 | 1:50 | Novocastra |
| p27 | 1B4 | 1:20 | Novocastra |
| Ki-67 | MIB-1 | 1:400 | Immunotech, Marseille, France |
| MUM1 | MUM1p (45) | 1:2 | Dr B. Falini |
| Antibody . | Clone . | Dilution . | Source . |
|---|---|---|---|
| CD20 | L26 | 1:80 | Dako, Carpinteria, CA |
| CD79a | JCB117 | 1:80 | Dako |
| CD3 | PS1 | 1:30 | Novocastra, Newcastle upon Tyne, England |
| CD5 | 4C7 | 1:25 | Novocastra |
| CD10 | 56C6 | 1:25 | Novocastra |
| bcl-2 | 124 | 1:50 | Dako |
| bcl-6 | PG-B6p (52) | 1:5 | Dr B. Falini, Perugia, Italy |
| CD138 | B-B4 | 1:10 | Serotec, Oxford, England |
| p53 | BP53-12 | 1:50 | Novocastra |
| p27 | 1B4 | 1:20 | Novocastra |
| Ki-67 | MIB-1 | 1:400 | Immunotech, Marseille, France |
| MUM1 | MUM1p (45) | 1:2 | Dr B. Falini |